SPONSOR
Sanofi Pasteur, a Sanofi Company
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Sanofi Pasteur, a Sanofi Company is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Meningococcal Infection, Acne.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sanofi Pasteur, a Sanofi Company
How many clinical trials has Sanofi Pasteur, a Sanofi Company sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Sanofi Pasteur, a Sanofi Company, of which 2 are actively recruiting participants. These trials cover conditions including Meningococcal Infection, Acne. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sanofi Pasteur, a Sanofi Company research focus on?
Sanofi Pasteur, a Sanofi Company clinical trials span Meningococcal Infection, Acne. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sanofi Pasteur, a Sanofi Company clinical trial?
To participate in a Sanofi Pasteur, a Sanofi Company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sanofi Pasteur, a Sanofi Company trials with current recruitment status updated daily.
Clinical Trials by Sanofi Pasteur, a Sanofi Company
NCT04843111
Recruiting
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
Meningococcal Infection
NCT07013747 Phase 1, Phase 2
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
Acne
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology